Literature DB >> 31406983

Prevalence and Patterns of Multimorbidity in a Nationally Representative Sample of Older Chinese: Results From the China Health and Retirement Longitudinal Study.

Shan-Shan Yao1,2, Gui-Ying Cao1,2, Ling Han3, Zi-Shuo Chen1,2, Zi-Ting Huang1,2, Ping Gong4, Yonghua Hu1,2, Beibei Xu1,2.   

Abstract

BACKGROUND: Multimorbidity has become a prominent problem worldwide; however, few population-based studies have been conducted among older Chinese with multimorbidity. This study aimed to examine the prevalence of multimorbidity and explore its common patterns among a nationally representative sample of older Chinese.
METHODS: This study used data from the China Health and Retirement Longitudinal Study and included 19,841 participants aged at least 50 years. The prevalence of individual chronic diseases and multimorbidity during 2011-2015 were evaluated among the entire cohort and according to residential regions and gender. The relationships between participants' demographic characteristics and multimorbidity were examined using logistic regression model. Patterns of multimorbidity were explored using hierarchical cluster analysis and association rule mining.
RESULTS: Multimorbidity occurred in 42.4% of the participants. The prevalence of multimorbidity was higher among women (odds ratio [OR] = 1.31, 95% confidence interval [CI]: 1.13-1.51) and urban residents (OR = 1.14, 95% CI: 1.02-1.27) than their respective counterparts after accounting for potential confounders of age, education, smoking, and alcohol consumption. Hierarchical cluster analysis revealed four common multimorbidity patterns: the vascular-metabolic cluster, the stomach-arthritis cluster, the cognitive-emotional cluster, and the hepatorenal cluster. Regional differences were found in the distributions of stroke and memory-related disease. Most combinations of conditions and urban-rural difference in multimorbidity patterns from hierarchical cluster analysis were also observed in association rule mining.
CONCLUSION: The prevalence and patterns of multimorbidity vary by gender and residential regions among older Chinese. Women and urban residents are more vulnerable to multimorbidity. Future studies are needed to understand the mechanisms underlying the identified multimorbidity patterns and their policy and interventional implications.
© The Author(s) 2019. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Gerontology; Health disparities; Multimorbidities; Public health

Year:  2020        PMID: 31406983     DOI: 10.1093/gerona/glz185

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  38 in total

1.  Frequency and types of clusters of major chronic diseases in 0.5 million adults in urban and rural China.

Authors:  Parisa Hariri; Robert Clarke; Fiona Bragg; Yiping Chen; Yu Guo; Ling Yang; Jun Lv; Canqing Yu; Liming Li; Zhengming Chen; Derrick A Bennett
Journal:  J Multimorb Comorb       Date:  2022-05-20

2.  Age, sex, residence, and region-specific differences in prevalence and patterns of multimorbidity among older Chinese: evidence from Chinese Longitudinal Healthy Longevity Survey.

Authors:  Siyue Han; Guangju Mo; Tianjing Gao; Qing Sun; Huaqing Liu; Min Zhang
Journal:  BMC Public Health       Date:  2022-06-04       Impact factor: 4.135

3.  Prevalence and patterns of multimorbidity in chronic diseases in Guangzhou, China: a data mining study in the residents' health records system among 31 708 community-dwelling elderly people.

Authors:  Wei-Quan Lin; Le-Xin Yuan; Min-Ying Sun; Chang Wang; En-Min Liang; Yao-Hui Li; Lan Liu; Yun-Ou Yang; Di Wu; Guo-Zhen Lin; Hui Liu
Journal:  BMJ Open       Date:  2022-05-25       Impact factor: 3.006

4.  Association of Depressive Symptoms with Rapid Kidney Function Decline in Adults with Normal Kidney Function.

Authors:  Zhuxian Zhang; Panpan He; Mengyi Liu; Chun Zhou; Chengzhang Liu; Huan Li; Yuanyuan Zhang; Qinqin Li; Ziliang Ye; Qimeng Wu; Guobao Wang; Min Liang; Xianhui Qin
Journal:  Clin J Am Soc Nephrol       Date:  2021-05-29       Impact factor: 10.614

5.  Associations between Multimorbidity and Physical Performance in Older Chinese Adults.

Authors:  Shan-Shan Yao; Xiangfei Meng; Gui-Ying Cao; Zi-Ting Huang; Zi-Shuo Chen; Ling Han; Kaipeng Wang; He-Xuan Su; Yan Luo; Yonghua Hu; Beibei Xu
Journal:  Int J Environ Res Public Health       Date:  2020-06-24       Impact factor: 3.390

6.  Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data.

Authors:  Yang Zhao; Rifat Atun; Brian Oldenburg; Barbara McPake; Shenglan Tang; Stewart W Mercer; Thomas E Cowling; Grace Sum; Vicky Mengqi Qin; John Tayu Lee
Journal:  Lancet Glob Health       Date:  2020-06       Impact factor: 26.763

7.  Multimorbidity patterns in old adults and their associated multi-layered factors: a cross-sectional study.

Authors:  Jiao Lu; Yuan Wang; Lihong Hou; Zhenxing Zuo; Na Zhang; Anle Wei
Journal:  BMC Geriatr       Date:  2021-06-19       Impact factor: 3.921

Review 8.  A Systematic Review of the Patterns of Associative Multimorbidity in Asia.

Authors:  Shawn S Rajoo; Zhi Jie Wee; Poay Sian Sabrina Lee; Fang Yan Wong; Eng Sing Lee
Journal:  Biomed Res Int       Date:  2021-07-03       Impact factor: 3.411

9.  Informal Caregiving, Chronic Physical Conditions, and Physical Multimorbidity in 48 Low- and Middle-Income Countries.

Authors:  Louis Jacob; Hans Oh; Jae Il Shin; Josep Maria Haro; Davy Vancampfort; Brendon Stubbs; Sarah E Jackson; Lee Smith; Ai Koyanagi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-07-13       Impact factor: 6.053

10.  Multimorbidity among Two Million Adults in China.

Authors:  Xiaowen Wang; Shanshan Yao; Mengying Wang; Guiying Cao; Zishuo Chen; Ziting Huang; Yao Wu; Ling Han; Beibei Xu; Yonghua Hu
Journal:  Int J Environ Res Public Health       Date:  2020-05-13       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.